| Dr Brian C Dawson, MD | |
|
984 Medical Dr Ste 1, Brigham City, UT 84302-4712 | |
| (435) 723-5248 | |
| (435) 723-5240 |
| Full Name | Dr Brian C Dawson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 984 Medical Dr Ste 1, Brigham City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265464960 | NPI | - | NPPES |
| 870282100012 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 359689-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Orem Community Hospital | Orem, UT | Hospital |
| Utah Valley Hospital | Provo, UT | Hospital |
| American Fork Hospital | American fork, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
The first results of a major all-Ireland study of twin pregnancies, led by Perinatal Ireland and the Royal College of Surgeons in Ireland (RCSI) and funded by the Health Research Board, has shown that a major difference in the birth weights among a pair of twin babies results in an increased risk of health complications for both twins.
SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today reported operational and financial results for its second quarter of fiscal year 2010, ended March 31, 2010.
Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.
Two new studies raise public health concerns about increasing antiviral resistance among certain influenza viruses, their ability to spread, and a lack of alternative antiviral treatment options.
› Verified 1 days ago
| Entity Name | Medical Arts Center Clinic Of Brigham City Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649375270 PECOS PAC ID: 9931000460 Enrollment ID: O20040117000175 |
News Archive
The first results of a major all-Ireland study of twin pregnancies, led by Perinatal Ireland and the Royal College of Surgeons in Ireland (RCSI) and funded by the Health Research Board, has shown that a major difference in the birth weights among a pair of twin babies results in an increased risk of health complications for both twins.
SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today reported operational and financial results for its second quarter of fiscal year 2010, ended March 31, 2010.
Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.
Two new studies raise public health concerns about increasing antiviral resistance among certain influenza viruses, their ability to spread, and a lack of alternative antiviral treatment options.
› Verified 1 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
The first results of a major all-Ireland study of twin pregnancies, led by Perinatal Ireland and the Royal College of Surgeons in Ireland (RCSI) and funded by the Health Research Board, has shown that a major difference in the birth weights among a pair of twin babies results in an increased risk of health complications for both twins.
SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today reported operational and financial results for its second quarter of fiscal year 2010, ended March 31, 2010.
Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.
Two new studies raise public health concerns about increasing antiviral resistance among certain influenza viruses, their ability to spread, and a lack of alternative antiviral treatment options.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian C Dawson, MD 984 Medical Dr Ste 1, Brigham City, UT 84302-4712 Ph: (435) 723-5248 | Dr Brian C Dawson, MD 984 Medical Dr Ste 1, Brigham City, UT 84302-4712 Ph: (435) 723-5248 |
News Archive
The first results of a major all-Ireland study of twin pregnancies, led by Perinatal Ireland and the Royal College of Surgeons in Ireland (RCSI) and funded by the Health Research Board, has shown that a major difference in the birth weights among a pair of twin babies results in an increased risk of health complications for both twins.
SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today reported operational and financial results for its second quarter of fiscal year 2010, ended March 31, 2010.
Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.
Two new studies raise public health concerns about increasing antiviral resistance among certain influenza viruses, their ability to spread, and a lack of alternative antiviral treatment options.
› Verified 1 days ago
Dr. Jeffrey R Lish, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 Fax: 877-395-5866 | |
Tye B Harrison, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W Hospital Rd, Brigham City, UT 84302 Phone: 435-734-2041 Fax: 435-723-8028 | |
Dr. Thomas Michael Matthews, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 W Hospital Rd, Brigham City, UT 84302 Phone: 435-734-2041 Fax: 435-723-8028 | |
Scott Mitchell Nagao, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 | |
Dr. James Robert Taylor, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 W Hospital Rd, Brigham City, UT 84302 Phone: 435-734-2041 Fax: 435-723-8028 | |
Dr. Michael C Shaw, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 Fax: 435-723-5240 |